Neurenati Therapeutics stands out as a pioneering biotechnology company dedicated to the development of an innovative treatment for Hirschsprung's disease. The collaboration between Nicolas Pilon, an expert in rare diseases, and Rodolphe Soret, a specialist in neuro-gastroenterology, has resulted in the creation of a promising treatment. Supported by serial entrepreneur Maxime Ranger and a team of experts in medicine, gastroen...
Neurenati Therapeutics stands out as a pioneering biotechnology company dedicated to the development of an innovative treatment for Hirschsprung's disease. The collaboration between Nicolas Pilon, an expert in rare diseases, and Rodolphe Soret, a specialist in neuro-gastroenterology, has resulted in the creation of a promising treatment. Supported by serial entrepreneur Maxime Ranger and a team of experts in medicine, gastroenterology, and clinical trials focused on rare diseases, Neurenati Therapeutics is committed to advancing this innovative treatment and ultimately making it available in clinical practice.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.